Your browser is no longer supported. Please, upgrade your browser.
Mesa Laboratories, Inc.
Index- P/E465.93 EPS (ttm)0.69 Insider Own3.00% Shs Outstand5.15M Perf Week1.83%
Market Cap1.68B Forward P/E144.74 EPS next Y2.21 Insider Trans-21.05% Shs Float4.94M Perf Month18.73%
Income4.10M PEG- EPS next Q0.17 Inst Own93.20% Short Float3.67% Perf Quarter16.97%
Sales138.90M P/S12.09 EPS this Y107.00% Inst Trans2.51% Short Ratio6.33 Perf Half Y31.33%
Book/sh77.45 P/B4.12 EPS next Y68.32% ROA0.70% Target Price286.67 Perf Year32.60%
Cash/sh52.41 P/C6.09 EPS next 5Y- ROE1.00% 52W Range232.88 - 325.50 Perf YTD11.35%
Dividend0.64 P/FCF43.38 EPS past 5Y-26.50% ROI2.40% 52W High-1.95% Beta0.33
Dividend %0.20% Quick Ratio9.10 Sales past 5Y9.60% Gross Margin64.00% 52W Low37.05% ATR9.61
Employees506 Current Ratio9.40 Sales Q/Q16.70% Oper. Margin8.60% RSI (14)70.54 Volatility3.35% 3.21%
OptionableNo Debt/Eq0.42 EPS Q/Q44.40% Profit Margin2.90% Rel Volume1.75 Prev Close322.44
ShortableYes LT Debt/Eq0.42 Earnings- Payout81.10% Avg Volume28.65K Price319.16
Recom2.30 SMA2011.38% SMA5012.80% SMA20017.79% Volume49,108 Change-1.02%
Jan-04-21Downgrade Evercore ISI Outperform → In-line $300
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $287
Oct-02-20Initiated JP Morgan Neutral $260
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Sep-14-21 01:02PM  
Sep-13-21 11:49AM  
Aug-22-21 10:38AM  
Aug-05-21 11:15AM  
Jul-29-21 03:05PM  
Jul-08-21 04:54AM  
Jul-06-21 07:19PM  
Jun-01-21 08:00AM  
May-31-21 03:00PM  
May-24-21 04:40AM  
Apr-19-21 12:42PM  
Apr-09-21 05:24AM  
Apr-05-21 05:00PM  
Feb-08-21 05:36AM  
Feb-03-21 09:25AM  
Feb-01-21 12:30PM  
Jan-05-21 05:00PM  
Dec-23-20 02:42AM  
Dec-09-20 01:52PM  
Nov-08-20 09:29AM  
Nov-05-20 10:25AM  
Oct-28-20 12:32PM  
Oct-01-20 04:00PM  
Sep-28-20 08:21AM  
Sep-25-20 01:34PM  
Sep-21-20 12:08PM  
Aug-06-20 03:00PM  
Aug-04-20 09:30AM  
Jul-28-20 12:33PM  
Jul-06-20 12:00PM  
Jun-16-20 11:53AM  
Jun-14-20 09:06PM  
Jun-09-20 08:15PM  
Jun-08-20 04:01PM  
Jun-01-20 09:25AM  
May-25-20 12:30PM  
May-15-20 08:00AM  
May-11-20 03:30PM  
Apr-22-20 09:13AM  
Apr-01-20 06:00PM  
Mar-16-20 11:04AM  
Mar-10-20 09:03AM  
Feb-10-20 08:00AM  
Jan-31-20 10:12AM  
Jan-27-20 12:30PM  
Jan-09-20 07:00PM  
Dec-16-19 06:12AM  
Nov-06-19 09:35AM  
Oct-31-19 08:55PM  
Oct-28-19 02:15PM  
Oct-23-19 10:33AM  
Oct-21-19 12:52PM  
Oct-01-19 05:00PM  
Sep-06-19 08:38AM  
Aug-07-19 11:20PM  
Aug-06-19 04:21PM  
Aug-01-19 10:27AM  
Jul-30-19 09:25AM  
Jul-23-19 10:32AM  
Jul-09-19 03:00PM  
Jul-04-19 04:10PM  
Jun-24-19 06:00PM  
Jun-17-19 01:20PM  
Jun-03-19 10:46AM  
May-04-19 09:42PM  
May-03-19 02:04PM  
Apr-08-19 01:44PM  
Mar-18-19 03:10PM  
Mar-06-19 08:00AM  
Feb-08-19 10:00AM  
Feb-04-19 09:20AM  
Jan-28-19 10:30AM  
Jan-08-19 08:00PM  
Jan-02-19 07:00PM  
Dec-25-18 09:31AM  
Dec-03-18 05:00AM  
Nov-30-18 09:15AM  
Nov-29-18 08:00AM  
Oct-31-18 08:39AM  
Oct-22-18 09:25AM  
Oct-11-18 01:57PM  
Oct-02-18 01:00PM  
Sep-27-18 08:43AM  
Sep-25-18 08:42AM  
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sakys JohnCFOSep 10Option Exercise89.701,400125,5808,914Sep 10 07:23 PM
Sakys JohnCFOSep 10Sale270.211,400378,2947,514Sep 10 07:23 PM
Sullivan John JamesDirectorSep 01Sale268.221,250335,27523,107Sep 01 04:45 PM
KELLY DAVID MDirectorAug 31Sale267.29603161,1762,600Sep 01 10:57 AM
Sullivan John JamesDirectorAug 18Option Exercise70.561,00070,56024,357Aug 19 10:58 AM
Sullivan John JamesDirectorAug 16Option Exercise89.705,192465,72228,549Aug 17 06:53 PM
Sullivan John JamesDirectorAug 16Sale272.165,1921,413,05523,357Aug 17 06:53 PM
GUILLEMIN EVANDirectorAug 15Option Exercise0.00308029,758Aug 16 01:44 PM
Sullivan John JamesDirectorAug 15Option Exercise0.00308023,357Aug 16 02:37 PM
Schmieder John BradleyDirectorAug 15Option Exercise0.00308071,015Aug 16 02:18 PM
KELLY DAVID MDirectorAug 15Option Exercise0.0030803,203Aug 16 02:10 PM
Alltoft Jennifer SadieDirectorAug 15Option Exercise0.0030801,215Aug 16 02:05 PM
Hall ShannonDirectorAug 15Option Exercise0.003080756Aug 16 01:55 PM
Sakys JohnCFOAug 12Option Exercise89.701,00089,7008,514Aug 13 01:49 PM
Sakys JohnCFOAug 12Sale275.161,000275,1607,514Aug 13 01:49 PM
Schmieder John BradleyDirectorAug 11Sale278.06800222,44870,707Aug 12 12:16 PM
Archbold Brian DavidSVP Continuous ImprovementAug 09Sale280.03639178,939154Aug 12 12:05 PM
Sullivan John JamesDirectorAug 02Sale290.471,250363,08823,049Aug 02 05:34 PM
GUILLEMIN EVANDirectorJul 16Sale282.18720203,17029,450Jul 19 09:17 AM
Sakys JohnCFOJul 12Option Exercise89.701,00089,7008,514Jul 13 12:02 PM
Sakys JohnCFOJul 12Sale278.771,000278,7707,514Jul 13 12:02 PM
Sakys JohnCFOJul 01Option Exercise89.701,00089,7008,514Jul 06 04:11 PM
Sakys JohnCFOJul 01Sale267.041,000267,0407,514Jul 06 04:11 PM
Sullivan John JamesDirectorJul 01Sale267.441,250334,30024,299Jul 06 10:48 AM
Archbold Brian DavidSVP Continuous ImprovementJun 17Sale256.56400102,624793Jun 21 10:21 AM
GUILLEMIN EVANDirectorJun 16Sale256.36720184,57930,170Jun 16 06:40 PM
Schmieder John BradleyDirectorJun 16Sale262.27505132,44671,507Jun 17 01:01 PM
Sakys JohnCFOJun 16Sale255.672,119541,7657,514Jun 17 12:50 PM
Owens Gary MPresident and CEOJun 16Sale255.676,5451,673,36018,396Jun 17 12:25 PM
DINOIA GREGORYSVP CommericialJun 16Sale255.671,211309,6162,973Jun 17 12:16 PM
Archbold Brian DavidSVP Continuous ImprovementJun 16Sale257.061,336343,4301,193Jun 17 12:06 PM
Alltoft Jennifer SadieDirectorJun 15Option Exercise0.002210907Jun 16 02:39 PM
Schmieder John BradleyDirectorJun 15Option Exercise0.00295072,012Jun 16 01:40 PM
Sullivan John JamesDirectorJun 15Option Exercise0.00340025,549Jun 16 01:25 PM
Hall ShannonDirectorJun 15Option Exercise0.001940448Jun 16 02:31 PM
GUILLEMIN EVANDirectorJun 15Option Exercise0.00295030,890Jun 16 02:04 PM
Sakys JohnCFOJun 15Option Exercise0.001,08605,436Jun 16 05:14 PM
Owens Gary MPresident and CEOJun 15Option Exercise0.003,537012,050Jun 16 04:55 PM
DINOIA GREGORYSVP CommercialJun 15Option Exercise0.0095901,799Jun 16 04:27 PM
Archbold Brian DavidVP of Continuous ImprovementJun 15Option Exercise0.007660920Jun 16 04:05 PM
KELLY DAVID MDirectorJun 15Option Exercise0.0029502,895Jun 16 02:20 PM
Sullivan John JamesDirectorJun 10Option Exercise76.581,00176,66025,209Jun 11 04:42 PM
Sullivan John JamesDirectorJun 08Option Exercise89.705,192465,72229,400Jun 09 11:54 AM
Sullivan John JamesDirectorJun 08Sale258.195,1921,340,52224,208Jun 09 11:54 AM
Owens Gary MPresident and CEOJun 07Sale264.001,350356,4008,513Jun 08 11:12 AM
KELLY DAVID MDirectorJun 04Option Exercise100.6785185,6683,451Jun 07 06:34 PM
DINOIA GREGORYSVP CommercialJun 04Option Exercise142.4054076,8961,380Jun 07 01:19 PM
DINOIA GREGORYSVP CommercialJun 04Sale260.27540140,546840Jun 07 01:19 PM
KELLY DAVID MDirectorJun 04Sale260.28851221,4982,600Jun 07 06:34 PM
Sullivan John JamesDirectorJun 01Sale251.462,215556,98424,208Jun 04 04:41 PM
GUILLEMIN EVANDirectorMay 17Sale244.25720175,86030,595May 18 12:49 PM
Sullivan John JamesDirectorMay 06Sale250.0520050,01032,859May 07 11:20 AM
Sullivan John JamesDirectorMay 05Sale250.5910025,05933,059May 07 11:20 AM
Sullivan John JamesDirectorMay 04Sale250.14735183,85333,159May 05 06:04 PM
GUILLEMIN EVANDirectorApr 16Sale253.77720182,71431,315Apr 19 10:52 AM
Sullivan John JamesDirectorApr 05Sale250.76500125,38057,458Apr 05 06:26 PM
GUILLEMIN EVANDirectorMar 16Sale269.48720194,02632,035Mar 16 07:57 PM
Sakys JohnCFOMar 12Option Exercise66.192,500165,4806,850Mar 15 09:50 AM
Sakys JohnCFOMar 12Sale263.842,500659,6004,350Mar 15 09:50 AM
Archbold Brian DavidSVP Continuous ImprovementMar 11Option Exercise129.1014518,720377Mar 11 10:24 AM
Archbold Brian DavidSVP Continuous ImprovementMar 10Sale271.7822360,607154Mar 11 10:24 AM
Sullivan John JamesDirectorMar 01Sale273.941,250342,42557,958Mar 02 10:43 AM
DINOIA GREGORYSVP CommericialFeb 23Sale276.7528077,490840Feb 24 10:47 AM
GUILLEMIN EVANDirectorFeb 16Sale281.523,6001,013,47232,755Feb 17 10:44 AM
Schmieder John BradleyDirectorFeb 10Sale278.231,750486,90371,717Feb 10 07:24 PM
Sullivan John JamesDirectorFeb 01Sale277.671,250347,08859,208Feb 01 06:59 PM
Schmieder John BradleyDirectorJan 12Sale285.23477136,05573,467Jan 12 10:27 AM
Sakys JohnCFOJan 08Option Exercise89.701,00089,7004,350Jan 11 02:26 PM
Sakys JohnCFOJan 06Option Exercise89.70161,4353,366Jan 07 11:40 AM
Sakys JohnCFOJan 06Sale290.00164,6403,350Jan 07 11:40 AM
Sullivan John JamesDirectorJan 04Sale280.821,250351,02560,458Jan 04 05:14 PM
KELLY DAVID MDirectorDec 11Sale283.1825070,7952,350Dec 14 11:57 AM
Sullivan John JamesDirectorDec 01Sale275.221,250344,02561,708Dec 01 07:36 PM
Sakys JohnCFONov 17Option Exercise89.7098488,2654,334Nov 18 12:40 PM
Sakys JohnCFONov 17Sale290.00984285,3603,350Nov 18 12:40 PM
KELLY DAVID MDirectorNov 16Option Exercise58.51179953,304Nov 18 11:09 AM
KELLY DAVID MDirectorNov 16Sale283.31704199,4502,600Nov 18 11:09 AM
Hall ShannonDirectorNov 15Option Exercise0.002540254Nov 16 09:56 AM
Sullivan John JamesDirectorNov 15Option Exercise0.00477062,958Nov 16 11:17 AM
KELLY DAVID MDirectorNov 15Option Exercise0.0047703,287Nov 16 11:07 AM
Alltoft Jennifer SadieDirectorNov 15Option Exercise0.004770686Nov 16 10:43 AM
Schmieder John BradleyDirectorNov 15Option Exercise0.00477073,944Nov 16 10:56 AM
GUILLEMIN EVANDirectorNov 15Option Exercise0.00477036,355Nov 16 11:59 AM
GUILLEMIN EVANDirectorNov 13Option Exercise41.802,05085,69037,928Nov 16 11:48 AM
GUILLEMIN EVANDirectorNov 13Sale274.302,050562,31535,878Nov 16 11:48 AM
GUILLEMIN EVANDirectorNov 12Option Exercise48.2795045,86036,828Nov 13 05:21 PM
GUILLEMIN EVANDirectorNov 12Sale273.77950260,08135,878Nov 13 05:21 PM
Sullivan John JamesDirectorNov 11Sale272.361,250340,45062,481Nov 12 12:24 PM
Archbold Brian DavidSVP Continuous ImprovementNov 09Option Exercise203.54533108,487765Nov 10 04:18 PM
Archbold Brian DavidSVP Continuous ImprovementNov 09Sale272.11533145,035232Nov 10 04:18 PM
Sakys JohnCFOOct 08Option Exercise89.7094284,4974,292Oct 09 06:29 PM
Sakys JohnCFOOct 08Sale276.90942260,8403,350Oct 09 06:29 PM
Owens Gary MPresident and CEOOct 08Sale276.9132389,4429,863Oct 09 06:20 PM
Owens Gary MPresident and CEOOct 07Sale275.00677186,17510,186Oct 09 06:20 PM
Owens Gary MPresident and CEOOct 06Sale265.001,000265,00010,863Oct 06 06:35 PM
DINOIA GREGORYSVP CommercialOct 02Option Exercise142.4027038,4481,452Oct 05 08:01 PM
DINOIA GREGORYSVP CommercialOct 02Sale260.0033286,3201,120Oct 05 08:01 PM